• 

  February 5, 2025

  United Therapeutics Breaks New Ground with FDA-Cleared Xenotransplantation Trial

  Ricky Solorzano

• 

  February 4, 2025

  Handheld Bioprinting with Kombucha-Based Bioink

  Ricky Solorzano

• 

  February 1, 2025

  Time Code: Improved Printing Code for 3D Bioprinting

  Ricky Solorzano

• 

  February 1, 2025

  MEDELLAPRO®: Endotoxin-Controlled Bioprinting Materials

  Ricky Solorzano

• 

  January 27, 2025

  Further Unlocking the Potential of 4D Bioprinting for Heart Tissue Engineering

  Ricky Solorzano

• 

  January 10, 2025

  Aspect Biosystems Secures $115M Series B to Advance Bioprinted Tissue Therapeutics

  Ricky Solorzano

• 

  January 7, 2025

  Stanford Open Source 3D Extrusion Bioprinter By Mark Skylar-Scott Lab

  Ricky Solorzano

• 

  December 13, 2024

  JOIN C-STARS: Exploring the Future of Space BioFabrication and Manufacturing

  Ricky Solorzano

• 

  December 3, 2024

  EpiBone Secures Funding Convertible Note to Drive Global Expansion of Clinical Trials

  Ricky Solorzano

• 

  December 2, 2024

  Engineering the Future of Vascularized Tissues: Programmable Bioinks Take Center Stage

  Ricky Solorzano